Anti-CCL21 Reference Antibody (Novartis patent anti-CCL21), Monoclonal

Produktübersicht

• Artikelname: Anti-CCL21 Reference Antibody (Novartis patent anti-CCL21), Monoclonal
• Artikelnummer: SYB-CHB811
• Hersteller Artikelnummer: CHB811
• Alternativnummer: SYB-CHB811-100UG, SYB-CHB811-1MG
• Hersteller: Sanyou Bio
• Kategorie: Antikörper
• Applikation: ELISA, FA, FACS, Kinetics

Produktbeschreibung

Anti-CCL21 Reference Antibody (Novartis patent anti-CCL21)(CHB811) is expressed from CHO. The heavy chain type is IgG1-REM, and the light chain type is lambdaC2. It has a predicted MW of 143.06 kDa.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1mg/ml
• UniProt: O00585
• Puffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Reinheit: >95%
• Formulierung: Lyophilize
• Target-Kategorie: CCL21